Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study
Affiliation
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, St Mary's Hospital, Research Floor, Oxford Road, Manchester, M13 9WL, UKIssue Date
2021
Metadata
Show full item recordAbstract
NoneCitation
Hawarden A, Russell B, Gee ME, Kayali F, Clamp A, Crosbie EJ, et al. Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study. BMC Cancer. 2021 May 26;21(1).Journal
BMC CancerDOI
10.1186/s12885-021-08369-4PubMed ID
34039290Additional Links
https://dx.doi.org/10.1186/s12885-021-08369-4Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1186/s12885-021-08369-4
Scopus Count
Collections
Related articles
- The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
- Authors: Gayarre J, Kamieniak MM, Cazorla-Jiménez A, Muñoz-Repeto I, Borrego S, García-Donas J, Hernando S, Robles-Díaz L, García-Bueno JM, Ramón Y Cajal T, Hernández-Agudo E, Heredia Soto V, Márquez-Rodas I, Echarri MJ, Lacambra-Calvet C, Sáez R, Cusidó M, Redondo A, Paz-Ares L, Hardisson D, Mendiola M, Palacios J, Benítez J, García MJ
- Issue date: 2016 Jan
- The road to long-term survival: Surgical approach and longitudinal treatments of long-term survivors of advanced-stage serous ovarian cancer.
- Authors: Javellana M, Hoppenot C, Lengyel E
- Issue date: 2019 Feb
- Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas.
- Authors: Hsu CY, Bristow R, Cha MS, Wang BG, Ho CL, Kurman RJ, Wang TL, Shih IeM
- Issue date: 2004 Oct 1
- [Clinicopathologic study and immunohistochemistry comparison of Pax2, p53 and Ki-67 in low- and high-grade ovarian serous carcinomas].
- Authors: Shen XX, Yu L, Bi R, Yang WT
- Issue date: 2011 Aug
- BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
- Authors: Petrillo M, Marchetti C, De Leo R, Musella A, Capoluongo E, Paris I, Benedetti Panici P, Scambia G, Fagotti A
- Issue date: 2017 Sep